Product Information
HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET is a generic product labeled by Elite Laboratories, Inc., priced at $0.1382 per EA under NDC 64850063201. Its NADAC has been published 64 times since Jun 4, 2025.
FDA first approved this application on Nov 16, 2018. Its Orange Book therapeutic-equivalence code is AA.
Strength
325; 7.5 mg/1; mg/1
Manufacturer
Elite Laboratories, Inc.NDC
64850063201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ACETAMINOPHEN; HYDROCODONE BITARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA209924FDA Approved
11/16/2018
TE Code
AA
On Market Since
11/16/2018
Pharmacological Classes
Price Statistics
The NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET has been published 64 times since Jun 4, 2025, and over the history we have for it it has declined 11.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1382 per EA |
|---|---|
| All-time high | $0.1556 (Jun 11, 2025) |
| All-time low | $0.1379 (Apr 22, 2026) |
| 52-week high | $0.1533 |
| 52-week low | $0.1379 |
| Median price | $0.1424 |
| Average price | $0.1450 |
| Largest weekly change | -4.2% (Dec 17, 2025) |
| Weeks tracked | 64 |
| Tracking since | Jun 4, 2025 |
Generic Alternatives
The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET, manufactured by Elite Laboratories, Inc., is $0.1382 per EA (NDC 64850063201), effective Aug 19, 2026.
How has the price of HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET changed over time?
Over the history we have for it, the NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET has declined 11.1%. It has been tracked across 64 weekly CMS publications since Jun 4, 2025.
What are the highest and lowest recorded NADAC prices for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?
Since Jun 4, 2025, the NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET has ranged from a low of $0.1379 (Apr 22, 2026) to a high of $0.1556 (Jun 11, 2025), with a median of $0.1424 per EA.
Are there cheaper alternatives to HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?
Yes. 12 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET, is $0.1272 per EA — about 8% below HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET.
Who manufactures HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?
HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET (NDC 64850063201) is labeled by Elite Laboratories, Inc., and CMS classifies it as a generic product.